Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Overview of attention for article published in JAMA Internal Medicine, January 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 101 news outlets
blogs: 4 blogs
policy: 2 policy sources
twitter: 262 X users
patent: 1 patent

facebook: 2 Facebook pages
wikipedia: 3 Wikipedia pages
reddit: 2 Redditors
podcasts: 2 podcasts

Readers on

mendeley: 626 Mendeley

So far, Altmetric has seen 4 posts from 4 blogs.

The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases

BrainImmune: Trends in Neuroendocrine Immunology, 06 Feb 2021

A few recent peer-reviewed or preliminary studies provide conflicting results about the efficacy of the interleukin-6 (IL-6…

Married couples have the same risk of a stroke or heart attack

Whats New, 26 Oct 2020

Married couples are equally at risk for a heart attack or stroke due to shared unhealthy habits such as smoking, poor nutrition…

Findings Conflicted for Benefit of Tocilizumab in COVID-19

Physician's Weekly, 26 Oct 2020

FRIDAY, Oct. 23, 2020 (HealthDay News) — Tocilizumab may be beneficial for adults with COVID-19 admitted to the intensive care…

Este fármaco antiinflamatorio podría ayudar a los pacientes con COVID-19 crítico

TekCrispy, 20 Oct 2020

Tocilizumab, un fármaco antiinflamatorio, parece ayudar a los pacientes con COVID-19 crítico, según los resultados de un nuevo…